Ranking results:

Past rankings:

2016
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2017	0	6.155.125	1.212.500		1
2016	0	8.291.218	745.669		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
EVONIK NUTRITION & CARE	1
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA	1
INSTITUT GUSTAVE ROUSSY	1
INSTITUTE OF MACROMOLECULAR CHEMISTRY ACADEMY OF SCIENCES OF THE CZECH REPUBLIC	1
IOX THERAPEUTICS LIMITED	1
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI	1
ITEOS THERAPEUTICS	1
LAMINAR PHARMACEUTICALS SL	1
LANA MANAGEMENT AND BUSINESS RESEARCH INTERNATIONAL LLC	1
LIPODOM KUTATO FEJLESZTO ES TANACSADO KORLATOLT FELELOSSEGU TARSASAG	1
ONCOARENDI THERAPEUTICS SPOLKA AKCYJNA	1
PRAXIS PHARMACEUTICAL	1
RESEARCH FUND OF THE HADASSAH MEDICAL ORGANIZATION	1
STICHTING KATHOLIEKE UNIVERSITEIT	1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	1
THE ROYAL MARSDEN NATIONAL HEALTH SERVICE TRUST	1
TTOPSTART BV	1
UNIVERSITA DEGLI STUDI DI SALERNO	1
UNIVERSITAET KONSTANZ	1
UNIVERSITAT DE LES ILLES BALEARS	1
UNIVERSITY OF NEWCASTLE UPON TYNE	1

Constancy:

Total number of partners: 21
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 21
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2017-12-01	A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma.	CLINGLIO	participant	6.155.125	12
2016-05-01	Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy	PRECIOUS	participant	8.291.218	11

SPECIALIZED MEDICAL SERVICES-ONCOLOGY BV - Netherlands